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Abstract: Faithful duplication of the genome is a challenge because DNA is susceptible to damage by
a number of intrinsic and extrinsic genotoxins, such as free radicals and UV light. Cells activate the
intra-S checkpoint in response to damage during S phase to protect genomic integrity and ensure
replication fidelity. The checkpoint prevents genomic instability mainly by regulating origin firing,
fork progression, and transcription of G1/S genes in response to DNA damage. Several studies hint
that regulation of forks is perhaps the most critical function of the intra-S checkpoint. However,
the exact role of the checkpoint at replication forks has remained elusive and controversial. Is the
checkpoint required for fork stability, or fork restart, or to prevent fork reversal or fork collapse,
or activate repair at replication forks? What are the factors that the checkpoint targets at stalled
replication forks? In this review, we will discuss the various pathways activated by the intra-S
checkpoint in response to damage to prevent genomic instability.
Keywords: DNA damage; intra-S checkpoint; ATR; Chk1; fork stability; origin regulation
1. Introduction
Genetic material is constantly subject to insults by both intrinsic and extrinsic factors [1,2]. Genetic
aberrations can also arise during replication of complex sequences that contain secondary structures or
repeats [3–5]. DNA damage checkpoints safeguard the genome against these insults and ensure its
faithful transmission across generations. Once activated, these checkpoints block cell cycle progression
and ensure that the DNA is fully repaired before allowing progression to the next phase of the cell
cycle [6]. However, even though the cell has checkpoints and repair pathways dedicated to DNA
damage repair in G1, it is impossible to guarantee that cells will enter S phase with a perfect template,
therefore the cell must be prepared to encounter damaged DNA during S phase [7–9]. In this review,
we will discuss the various tactics employed by the intra-S checkpoint to minimize the casualties of
S-phase DNA damage.
2. Source of Damage
2.1. Intrinsic Sources of Damage
DNA can be damaged by numerous intrinsic and extrinsic factors [1,2]. Intrinsic factors
include reactive oxygen species (ROS) generated as a by-product of cellular metabolism, which
can cause oxidative damage to DNA. Other toxic metabolites include reactive aldehydes generated
via alcohol metabolism, which can crosslink DNA [10,11]. Apart from toxic by-products of
metabolism, ribonucleotides can pose a threat, too [12]. Despite the specificity of DNA polymerases
for deoxyribonucleotides over ribonucleotides, recent studies have shown that more than 10,000
ribonucleotides may be incorporated into the Saccharomyces cerevisiae genome during replication
and can cause genomic stress if not actively removed [13,14]. In unperturbed cells, ribonucleotides
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are removed from the genome using a combination of ribonuclease H (RNaseH) activity and
post-replication repair pathways. Replication stress can also be caused be intrinsically difficult to
replicate sequences in the genome, such as G-quadruplexes and repeats, which can lead to replication
fork slippage and chromosomal breaks [3,4,15]. Another natural impediment to the replication fork
is the transcriptional machinery. Collision between the replication and the transcription machinery
leads to fork stalling, R-loop formation, and topological stress, which may trigger DNA damage and
recombination [16,17]. Cells have active mechanisms to constrain the deleterious effects of all these
aberrations, so as to curtail their impact on the genome.
2.2. Extrinsic Sources of Damage
Extrinsic factors that damage DNA include ultra-violet light (UV) and ionizing radiation (IR), and
chemicals such as methyl-methane sulfonate (MMS), mitomycin C, cisplatin, psoralen, camptothecin
(CPT), and etoposide, to list a few of the well-known DNA damaging agents. These damaging
agents cause different kinds of lesions, from simple alkylation of bases by MMS, to the more complex
pyrimidine dimers by UV, topoisomerase-DNA covalent complexes by CPT, and inter-strand and
intra-strand crosslinks by cisplatin and psoralen [18–21]. Cells have evolved various pathways to
specifically detect and repair different kinds of lesions. The repair pathways include base excision
repair (BER), which targets modified bases, nucleotide excision repair (NER) pathway, which targets
more complex modifications such as pyrimidine dimers. Inter-strand crosslinks are repaired using
inter-strand crosslink repair pathway, which involves a combination of repair pathways consisting of
NER, homologous recombination (HR), TLS (translesion synthesis), and Fanconi anemia (FA) repair
pathways. Finally, double strand breaks (DSB) are repaired by non-homologous end-joining (NHEJ)
and HR pathways [1,8,18,21–26].
3. The Intra-S Checkpoint
Despite having specific repair pathways dedicated to each kind of DNA lesion, the cell relies on
a single checkpoint to mediate the DNA damage response during S phase. The cell has two main
checkpoint kinases, Ataxia Telangiectasia Mutated (ATM) and ATM and Rad3-related (ATR), both of
which are critical for maintaining genomic integrity. Of the two, ATR is the more crucial mediator of
intra-S checkpoint responses since it is activated in response to diverse lesions. ATM (Tel1 in budding
and fission yeast) mainly responds to double strand breaks, while ATR (Mec1 in budding yeast, Rad3
in fission yeast) is activated in response to a variety of genotoxins such as UV, MMS, hydroxyurea
(HU), aphidicolin, and psoralen. ATR also functions in every unperturbed S phase, where it regulates
origin firing [27–32]. Since several different pathways activate ATR in response to diverse lesions,
it has been suggested that the checkpoint is activated by a common repair intermediate [33–39].
4. Detection of Lesion During S Phase
The first step key to all repair pathways is the detection of the lesion itself. Detection of a lesion can
be a challenge in the vast pool of undamaged template [9,23]. Furthermore, individual damaged bases
must be detected in the context of DNA complexed with protein and condensed into chromatin [40].
Depending on the severity of lesions, certain aberrations may be detected only during the act of
replication itself. The replication fork is a sensitive detector of lesions, since it has to interact with
every base in the genome during replication. Several studies have shown that lesions caused by UV
and MMS activate the checkpoint only during S phase [41–46]. Studies in S. cerevisiae have shown that,
if replication initiation is blocked using conditional alleles of initiation factors such as Cdc6, or Cdc45,
or Cdc7, then cells undergo nuclear division without replicating DNA or activating the checkpoint
even when treated with 0.033% MMS, demonstrating that this level of damage is not recognized
outside of S phase [43]. However, during S phase, as little as 0.005% MMS is sufficient to activate
the checkpoint, suggesting that the replication fork is a highly sensitive and efficient activator of
the checkpoint [43]. Similarly, in Xenopus extracts, prevention of replication by addition of geminin
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blocks checkpoint activation in response to UV and MMS induced lesions [44,45]. In human cells too,
ATR activation in response to UV requires replication [47].
UV- and MMS-induced lesions at high concentrations can activate the DNA damage checkpoint
outside S phase. Such activation relies on repair pathways such as BER in the case of MMS-induced
lesions and NER in the case of UV-induced lesions to generate intermediate structures capable of
activating the checkpoint [48–53]. Thus, the checkpoint can be activated by stalled replication forks as
well as intermediate structures generated by repair pathways in response to diverse lesions caused by
different agents such as UV, MMS, and aphidicolin [34].
5. Intra S-Checkpoint Activation
5.1. The Structure Necessary for Checkpoint Activation
The fact that ATR is activated in response to different kinds of genotoxins suggests that the
activation might occur not through recognition of damage itself but a common intermediate generated
in response to any lesion that perturbs replication. Several studies indicate that the common
intermediate necessary for checkpoint activation is replication protein A (RPA)–single-stranded DNA
(ssDNA) complex [35,36,54–58]. Replicative polymerases tend to stall in response to lesions while
the helicase continues to unwind the DNA ahead of the lesion. Such uncoupling of the helicase and
the polymerase leads to generation of ssDNA, which gets coated with the ssDNA binding protein
RPA [35,36,57,58]. This common intermediate comprised of stalled replicative polymerase allows for a
simple mode of checkpoint activation by diverse lesions [35,36]. In the cases of double-strand breaks
and inter-strand crosslinks—which do not directly produce ssDNA—lesion processing creates ssDNA,
as described below.
5.2. The Factors Necessary for Checkpoint Activation
Several studies have shown that RPA coated ssDNA is essential for activation of the S-phase
checkpoint kinase, ATR [54,57–60]. ATR is a highly-conserved checkpoint kinase, which responds
to various kinds of lesions that block DNA replication [61,62]. RPA bound ssDNA interacts with
ATR-interacting protein (ATRIP) (Ddc2 in budding yeast, Rad26 in fission yeast), which binds ATR,
leading to its recruitment to sites of DNA damage (Table 1) [57,60,63,64].
Table 1. List of key proteins involved in intra-S checkpoint activation conserved across species.
Title 1 S. cerevisiae S. pombe Mammals
Checkpoint kinase
Mec1
Ddc2
Rad24
Rad3
Rad26
Rad17
ATR
ATRIP
Rad17
Sensors
Ddc1
Mec3
Rad17
Dpb11
Rad9
Hus1
Rad1
Cut5
Rad9
Hus1
Rad1
TopBP1
Adaptors
Mrc1
Tof1
Csm3
Mrc1
Swi1
Swi3
Claspin
Tim
Tipin
Effector kinase Rad53 Cds1 Chk1
The stalled fork junction composed of ssDNA-RPA complex and dsDNA further recruits
Rad17-RFC complex, which loads a trimeric ring-shaped complex Rad9-Rad1-Hus1 (9-1-1) at sites
of damage, although it is unclear if Rad17-RFC recognizes the 3'ds/ssDNA junction, perhaps after
polymerase release or a 5'ds/ssDNA junction, which would be created by repriming ahead of a stalled
polymerase on either the leading or lagging strand (Figure 1) [65,66].
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subsequently recruits ATR-ATRIP, Rad17/9-1-1, TopBP1 leading to ATR activation. Rad17/9-1-1 
complex further recruits adaptors like Claspin which leads to transduction of the signal to the effector 
kinase Chk1. Chk1 and ATR phosphorylate a wide range of substrates affecting several aspects of 
cellular physiology in response to damage such as transcription, replication kinetics, modulation of 
nuclear membrane processes and alteration of chromatin structure. 
9-1-1 complex in turn recruits DNA topoisomerase II binding protein 1 (TopBP1) (Dpb11 in 
budding yeast, Cut5 in fission yeast), which further stimulates ATR activity. [66–75]. Rad17-RCF and 
9-1-1, together with regulators Claspin (Mrc1 in budding and fission yeast) and Tim/Tipin 
(Tof1/Csm3 in budding yeast, Swi1/Swi3 in fission yeast), are essential for activation of checkpoint 
kinase 1 (Chk1), which is the main target of ATR and the effector kinase in the checkpoint pathway 
in metazoa (Figure 1) [76–85]. 
5.3. Downstream Effectors of Checkpoint Activation 
ATR and ATM activate two effector kinases, Chk1 and Chk2, in response to damage to relay the 
checkpoint signal across the cell. While ATR and ATM mainly target substrates at the chromatin close 
to the site of lesion, the effector kinases freely diffuse and transduce the signal to distant substrates 
Figure 1. Intra-S checkpoint activation. Fig1 depicts how a stalled fork generates RPA-ssDNA which
subsequently recruits ATR-ATRIP, Rad17/9-1-1, TopBP1 leading to ATR activation. Rad17/9-1-1
complex further recruits adaptors like Claspin which leads to transduction of the signal to the effector
kinase Chk1. Chk1 and ATR phosphorylate a wide range of substrates affecting several aspects of
cellular physiology in response to damage such as transcription, replication kinetics, modulation of
nuclear membrane processes and alteration of chromatin structure.
9-1-1 complex in turn recruits DNA topoisomerase II binding protein 1 (TopBP1) (Dpb11 in
budding yeast, Cut5 in fission yeast), which further stimulates ATR activity [66–75]. Rad17-RCF and
9-1-1, together with regulators Claspin (Mrc1 in budding nd fission yeast) and Tim/Ti in (Tof1/Csm3
in bu ding yeast, Swi1/Swi3 in fission yeast), are essential for activation of checkpoint kinase 1
(Chk ), which is the main target of ATR and the effector kinase in the checkpoint p thw y in metazoa
(Figure 1) [76–85].
5.3. Downstream Effectors of Checkpoint Activation
ATR and ATM activate two effector kinases, Chk1 and Chk2, in response to damage to relay the
checkpoint signal across the cell. While ATR and ATM mainly target substrates at the chromatin close to
the site of lesion, the effector kinases freely diffuse and transduce the signal to distant substrates [86–92].
In mammals, Chk1 and Chk2 play overlapping roles. Although Chk1 is primarily activated by ATR
in response to various kinds of lesions and Chk2 by ATM in response to DSBs, there is substantial
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cross-talk between the two pathways making it difficult to unambiguously assign Chk1 and Chk2 to a
single checkpoint pathway [7,80,93–99]. The roles played by Chk1 and Chk2 also vary substantially
across species [100]. In budding and fission yeasts, Rad53 and Cds1 are homologs of mammalian Chk2,
respectively. However, they are functionally equivalent to mammalian Chk1. In budding yeast Rad53
is required for the intra-S checkpoint as well as G2/M checkpoint responses, while Cds1 in fission
yeast acts only during S phase [61,101–104].
Inter-strand crosslinks also activate ATR, even though they do not generate RPA-ssDNA in the
canonical way by uncoupling helicase and the polymerase. To activate ATR, inter-strand crosslinks
rely on the FA pathway. Processing of the inter-strand crosslink by the FA pathway leads to generation
of ssDNA-RPA, which in turn activates ATR. Inhibition of FA pathway or depletion of FANCD2 greatly
diminishes Chk1 activation in response to inter-strand crosslinks [105,106].
6. Strength of Checkpoint Activation
Replication initiation involves melting of DNA, which produces RPA-coated ssDNA, the structure
necessary for checkpoint activation. Therefore, one complication of checkpoint activation via
RPA-ssDNA complex is that it is a common intermediate generated even during an unperturbed
S phase. Several studies indicate that the checkpoint functions in every S phase even in the
absence of damage. The importance of this function is suggested by the fact that inhibition of Chk1
during unperturbed S phase leads to unrestrained origin firing, which is detrimental to genomic
stability [27–32]. The effect of the checkpoint during unperturbed replication can also be seen in
Xenopus extracts, where the rate of replication decreases with increasing concentration of template in a
checkpoint-dependent manner [27,107]. Therefore, it appears that the ssDNA-RPA structures of many
unperturbed replication forks are capable of collectively activating the checkpoint, even in the absence
of damage.
Even though the checkpoint is activated in every S phase, there is a quantitative difference
between level of activation during an unperturbed S phase and level required to be induced by
DNA damage to activate a full-strength checkpoint response. The level of Chk1 activation is tightly
correlated with the amount of ssDNA generated. In the presence of fork stalling lesions the helicase
becomes uncoupled from the polymerase leading to generation of longer stretches of ssDNA than
present in an unperturbed fork [58]. The excess ssDNA-RPA complex formed in response to DNA
damage leads to robust activation of the checkpoint. Titration experiments with plasmids of varying
sizes in Xenopus extracts show that the amount of ssDNA generated determines the strength of Chk1
activation [58]. Along similar lines, the number of active forks determine the activation of Rad53 in
response to DNA damage in S. cerevisiae [108].
Although double strand breaks primarily activate ATM, resection of their ends leads to ssDNA
generation leading to subsequent activation of ATR [95,96,109–112]. The strength of checkpoint
activation and subsequent cell cycle delay in response to DSB is regulated by both the number of DSBs
generated and the amount of ssDNA generated at each DSB [112–114]. Thus, the checkpoint activation
can be quantitatively modulated by the amount of ssDNA generated in response to different kinds
of lesions.
7. Downstream Targets
Unlike ATR, which mainly phosphorylates substrates on chromatin, the S-phase effector kinases
transduce the signal to many targets across the cell [86–92]. Activation of Chk1 in metazoans and
Rad53 and Cds1 in yeast in response to replication stress leads to regulation of replication kinetics via
inhibition of origin firing and regulation of replication forks, and to transcriptional reprogramming.
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8. Transcriptional Regulation by the Checkpoint
8.1. G1/S Regulation
In both mammals and yeast, the S-phase checkpoint maintains transcription of G1/S genes,
which are normally turned off as the cells progress through S phase. In mammals, Chk1 regulates
the E2F family of transcription factors, whose targets are involved in DNA metabolic processes and
DNA repair. Repression of E2F targets during a replication stress response generates further DNA
damage signals and hampers cell survival, demonstrating the importance for checkpoint-dependent
maintenance of their expression during replication stress [115]. Along similar lines, expression of
G1/S genes are maintained in response to replication stress in S. cerevisiae and S. pombe. Mlu1-box
binding factor (MBF) induces the expression of G1/S transition genes, which are inactivated by the
Nrm1 transcriptional repressor as cells progress through S phase. Both Rad53 in S. cerevisiae and Cds1
in S. pombe phosphorylate and inactivate Nrm1 to maintain expression of G1/S genes in response to
replication stress [116–119].
In S. cerevisiae, the importance of transcriptional responses activated by the checkpoint is not
clear. Several independent studies have shown that Rad53 maintains S-phase transcription of several
hundreds to thousands of genes in response to damage. However, since these genes constitute the
entire G1/S regulon, most of the upregulated transcripts do not encode for DNA repair proteins or
proteins whose deletion induces sensitivity in response to DNA damage [120–123]. Furthermore,
Tercero et al., have shown that new protein synthesis is not necessary to resume fork synthesis or
maintain cell viability when released from a hydroxyurea (HU) arrest [43]. However, it is unclear
whether new protein synthesis is dispensable when forks actively encounter fork-stalling lesions as in
the case of MMS treatment during S phase. In S. pombe, the maintenance of specific G1/S transcripts
has been shown to contribute to resistance to replication stress [117,124,125].
8.2. RNR Regulation
In addition to maintenance of S-phase transcription in response to damage, the checkpoint
also regulates RNR (ribonucleotide reductase) activity, which is required for deoxynucleotide
triphosphate (dNTP) synthesis [126–143]. In budding yeast, activated Rad53 induces RNR expression
by phosphorylating the Dun1 kinase, which in turn phosphorylates and inactivates Rfx1 (aka Crt1).
Rfx1 transcriptionally represses RNR genes by recruiting Tup1-Ssn6, thus its inactivation strongly
induces RNR expression [126]. In a similar manner, fission yeast and mammalian cells also upregulate
transcription of RNR genes in a checkpoint dependent manner [130,131].
Apart from transcriptional regulation, RNR activity is also modulated through regulation of
its localization as well as by small protein inhibitors. In budding yeast, Dun1 phosphorylates Dif1,
a protein that sequesters Rnr2-Rnr4 subunits in the nucleus and thus prevents the subunits from
forming an active complex together with the Rnr1 subunit in the cytoplasm. Phosphorylation of
Dif1 triggers its degradation leading to release of Rnr2-Rnr4 to the cytoplasm [135,136]. Dun1 also
phosphorylates Sml1, an inhibitor of Rnr1 and targets it for degradation [137]. In fission yeast,
the checkpoint targets Spd1 for degradation, which affects both localization and activity of RNR
subunits [139–143]. Furthermore, a related protein Spd2 may also affect RNR regulation in fission
yeast [144]. A recent study in mammalian cells has identified Inositol 1,4,5-triphosphate (IP3) receptor
binding protein released with IP3 (IRBIT) as an inhibitor of RNR activity, however its regulation by
the checkpoint is yet to be determined [145]. Thus, using multiple mechanisms dNTP production
is increased in response to damage, which greatly improves cell viability [128,139,146]. Of the three
model organisms, budding yeast shows the most dramatic increase in dNTP levels in response to
damage, which perhaps explains why S. cerevisiae is resistant to much higher concentrations of HU
than other organisms [138,139,146].
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9. Regulation of Replication Kinetics by the Checkpoint
Slowing of replication in response to DNA damage has been documented for more than half a
century [147–150]. The initial hints of checkpoint regulation of replication slowing came from Ataxia
Telangiectasia (AT) patients, characterized by hypersensitivity to IR. Cells from AT patients fail to
slow replication in response to IR, a characteristic termed ‘radio-resistant DNA synthesis’ [151–154].
AT patients suffer from severe developmental defects and are highly predisposed to developing
cancer [155,156]. The symptoms of AT patients highlight the importance of checkpoint regulated
slowing of replication in response to damage. Later studies in S. cerevisiae and S. pombe showed that
slowing of S phase is an evolutionarily conserved mechanism in response to DNA damage [102,103,157].
This bulk slowing of replication is achieved through a combination of inhibition of origin firing and
regulation of fork progression.
10. Inhibition of Origin Firing
Replication of the genome occurs in a temporally ordered manner with different parts of the
genome replicating at specific times in S phase [158]. In the presence of damage, the early origins
fire regardless of the presence of lesions, since the forks established by early origins are the ones
which sense the lesions and activate the checkpoint. Once the checkpoint is activated, it suppresses
firing of late origins [159–168]. In S. cerevisiae, Rad53 phosphorylates the origin activation factors
Sld3 and Dbf4 in response to replication stress to prevent subsequent origin firing [169,170]. Sld3
is a replication-fork assembly factor required during early steps of replication initiation; Dbf4 is the
regulatory subunit of Dbf4-dependent kinase (DDK), which is required for origin firing and fork
progression [171–173]. In mammals, Chk1 targets multiple substrates to block origin firing. In response
to IR, Chk1 phosphorylates Cdc25A, targeting it for ubiquitin-mediated degradation. Cdc25A is
a phosphatase necessary for Cdk2-CyclinE activity, which is required for binding of Cdc45 to the
pre-replicative complex (pre-RC) and initiating replication [30,163]. Chk1 also phosphorylates Treslin,
the metazoan homolog of Sld3, to prevent loading of Cdc45 onto chromatin [174]. Further studies in
Xenopus and mammalian cells suggest that Chk1 also targets DDK in response to UVC and etoposide
treatments [59,175,176]. Inhibition of origin firing prevents new forks from encountering damage and
stalling. Although reduction in origin firing leads to slowing of replication, which is critical, it does
not significantly contribute to maintenance of cell viability, at least not in S. cerevisiae [43].
10.1. Activation of Dormant Origins
Although checkpoint activation inhibits origin firing globally, several reports suggest that it might
allow dormant origins to fire locally in response to replication stress [177,178]. Cells license origins
during G1 phase of the cell cycle and activate them throughout S phase [179–182]. In an unperturbed
S phase, a cell fires only about 10% of its licensed origins [178,183,184]. Most of the remaining origins
are licensed but not fired and hence referred to as dormant origins. During unperturbed replication,
dormant origins are passively replicated. However, in the event of replication stress, forks from early
origins stall and the dormant origins remain un-replicated. Under such conditions, the dormant origins
fire and help complete replication in the vicinity of stalled forks and thereby mitigate the consequences
of fork stalling. Reduction of dormant origin firing via depletion of mini-chromosome maintenance
(MCM) complex makes the cell hypersensitive to replication perturbation, highlighting the importance
of dormant origins [183,185–187]. At this point, it is unclear how the checkpoint could suppress origin
firing globally but permit activation of dormant origins in response to replication stress. A possible
explanation is that the checkpoint reduces origin firing globally, but that even so dormant origin firing
increases due to the reduction in passive replication [177,178].
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11. Fork Regulation
11.1. Importance of Fork Regulation
Several studies suggest that the regulation of replication forks in response to replication stress is
the crucial function of the intra-S checkpoint. The first hint of the importance of fork regulation came
from the discovery of a separation of function mutant in budding yeast called mec1-100 [188]. mec1-100
cells cannot suppress origin firing in response to stress, but are not hypersensitive to MMS, unlike
mec1∆ cells [43,188]. Presumably fork regulation is intact in mec1-100, hinting that fork regulation is
more critical for cell viability in response to MMS than origin firing inhibition. Consistent with this
conclusion, Tercero et al. have shown that forks progress slowly but stably in mec1-100 to complete
replication in response to MMS [43]. In contrast, in mec1∆ and rad53∆ cells treated with HU or MMS,
forks collapse irreversibly leading to large stretches of un-replicated DNA [42,189]. Experiments in
which Rad53 expression is suppressed during HU treatment but induced after release from HU arrest
show that the checkpoint is necessary at the time of fork stalling to maintain the replication fork in
a restart competent manner. Expression of Rad53 after release from HU arrest is not sufficient to
maintain viability [43]. Along similar lines in mammals, ATR-/- and CHK1-/- are embryonic lethal
in mice and inactivation of ATR during replication stress greatly hampers fork progression and cell
viability [190–192]. Collectively, these studies suggest that the checkpoint is essential for preventing
fork collapse in response to replication stress. The mechanism by which the checkpoint accomplishes
fork stabilization and maintains cell viability is not understood.
11.2. Regulation of Number of Forks
In response to replication stress, suppression of late firing origins limits the generation of an
excess number of stalled forks. Unrestrained firing of origins in the presence of replication stress might
overwhelm the capacity of the checkpoint to attenuate the consequences of stalled forks. Supporting
this idea, Toledo et al. observed that in the absence of ATR activity, excess firing of origins in response
to HU depletes the nuclear pool of RPA leading to DSB generation [193]. Therefore, the critical role
of the checkpoint may not be to regulate the fork per se but to curtail origin firing in response to
replication stress so as to avoid generation of an excess number of stalled forks. However, it is yet to
be determined whether replication forks from ATR inhibited cells supplemented with excess RPA are
capable of stably progressing and completing replication when released from HU arrest. Furthermore,
HU treatment in the absence of a checkpoint leads to excessive unwinding and generation of longer
stretches of ssDNA as compared to cells in which the checkpoint activity is intact [194]. Therefore,
RPA may have a more critical role under excessive unwinding, as seen in checkpoint mutants, than in
wild-type cells.
11.3. Maintenance of Replisome Stability
The most controversial role of the checkpoint at stalled forks is the maintenance of replisome
stability [195,196]. Replisome stability refers to the physical association of the replisome factors with
the stalled replication fork (Figure 2a).
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can bypass damage by recruiting translesion ploymerase in an error prone manner. Recruitment of 
translesion polymerase requires mono-ubiquitination of PCNA; (e) Template switching. A stalled 
fork can bypass damage by using the lagging strand as a template instead of the damaged parental 
strand. Template switching requires poly-ubiquitination of PCNA. 
Several chromatin immuno-precipitation (ChIP) studies done in budding yeast have suggested 
that, in response to HU, polymerases and helicases tend to dissociate from the stalled fork in the 
absence of an active checkpoint [197–201]. Similarly, studies in Xenopus and mammalian cells have 
Figure 2. Regulation of forks in response to damage. (a) Replisome stability pertains to stable
association of replisome components; (b) Fork reversal in response to damage, wherein the leading
strand anneals with the lagging strand to form a four-way structure. Fork reversal is opposed by
nucleases such as Exo1, Dna2; (c) Downstream repriming. Leading strand can bypass damage by
repriming downstream of the stalled fork; (d) Translesion polymerase based synthesis. A stalled fork
can bypass damage by recruiting translesion ploymerase in an error prone manner. Recruitment of
translesion polymerase requires mono-ubiquitination of PCNA; (e) Template switching. A stalled fork
can bypass damage by using the lagging strand as a template instead of the damaged parental strand.
Template switching requires poly-ubiquitination of PCNA.
Several chromatin immuno-precipitation (ChIP) studies done in budding yeast have suggested
that, in response to HU, polymerases and helicases tend to dissociate from the stalled fork in the
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absence of an active checkpoint [197–201]. Similarly, studies in Xenopus and mammalian cells have
shown that several components of the replisome are lost from forks stalled in response to prolonged
treatment with aphidicolin in the absence of ATR [202–204]. However, contrary to these studies,
De Piccoli et al. have shown—using genome-wide ChIP-seq—that the replisome components remain
stably associated with forks stalled in HU even in the absence of Rad53 or Mec1 in budding yeast [205].
Perhaps the discrepancy between these reports can be explained by the differences between their ChIP
assays. The former focused on early origins with ChIP PCR probes designed at close proximity to the
early origins as opposed to genome-wide ChIP-seq by the latter, which gives a more comprehensive
picture. The latter work shows that, in the absence of checkpoint, forks from early origins continue
to replicate longer and hence stall replisome components further downstream than they would
in wild-type cells [205]. Thus, by ChIP-PCR with probes designed at close proximity to the early
origins, the replisome components appear to be intact in wild-type and depleted in the checkpoint
mutant [205]. However, at this point, it remains a matter of debate whether the checkpoint affects the
physical association of the replisome components or only regulates their functionality in response to
replication stress [196].
Most studies trying to understand the role of checkpoint in maintaining replisome stability have
focused on forks stalled for a prolonged duration (20 to 60 min) in response to HU arrest. Stalling
forks in the order of tens of minutes in response to HU might be biologically very different than fork
pausing briefly in response to MMS-induced lesions. It is not clear whether stability of the replisome
components is affected if the fork stalls are short-lived as compared to that in a HU arrest. Therefore,
the mechanism by which Rad53 allows the forks to progress slowly but stably and complete replication
of the whole genome in response to MMS remains unclear.
11.4. Fork Reversal
Regardless of whether the checkpoint affects replisome stability or not, it prevents accumulation
of pathological structures at stalled replication forks. rad53 mutants accumulate structures similar
to those obtained by destabilizing replisome components as monitored by 2D gels [189]. Similarly,
electron microscopy (EM) studies have shown that HU treatment of rad53∆ cells leads to excessive
unwinding and generation of longer stretches of ssDNA as compared to wild-type cells [194].
Furthermore, rad53∆ cells accumulate reversed forks wherein the leading strand is unwound and
anneals with the lagging strand to form a four-way structure (Figure 2b) [194,199]. Whether reversed
forks are a pathological structure or productive repair intermediates is uncertain. In yeast, fork
reversal is mainly observed in the absence of checkpoint and therefore appears to be pathological.
However, in metazoans, fork reversal appears to be a part of DNA damage tolerance mechanism [206].
Chaudhuri et al. have shown that in mammalian cells, Xenopus extracts, and yeast cells, low doses of
CPT treatment lead to fork reversal. In mammals, reversal of forks is mediated by poly (ADP-ribose)
polymerase 1 (PARP1) [207]. Depletion of PARP1 prevents fork reversal and leads to double strand
break formation [207]. Furthermore, Rad51 dependent fork reversal is seen in human cells in response
to a variety of genotoxins [208]. Thus, in mammals, fork reversal appears to play a protective
role. However, in the absence of checkpoint, nucleases such as Mus81 and Slx4 can improperly
process reversed forks leading to genomic instability [190,209,210]. Thus, fork reversal itself may
not be pathological, but its regulation by the checkpoint may prevent deleterious outcomes. In vitro
biochemical studies have identified several helicases and translocases such as Rad54, WRN, BLM, HLTF,
FANCM, FBH1, SMARCAL1, and ZRANB3 capable of regressing forks [211–223]. However, of all these
factors, only Rad51 and FBH1 have been shown to be required for fork regression in vivo [208,221].
Furthermore, how helicases and translocases may be regulated by the checkpoint at stalled forks is
not known.
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11.5. Regulation of Nucleases
There is mounting evidence that the checkpoint plays a role in protecting forks from aberrant
activity of nucleases. Support for this idea comes from Segurado and Diffley, 2008 work, which
shows that deletion of EXO1 rescues rad53∆ sensitivity to several genotoxins like UV, MMS, and IR
all except HU [224]. Phospho-proteomic screens have also identified Exo1 as a target of Rad53 and
this phosphorylation has been shown to negatively regulate Exo1’s activity [88,225]. Furthermore, EM
studies in budding yeast have shown that Exo1 creates ssDNA intermediates of reversed forks and
drives fork collapse in the absence of Rad53 [199]. However, deletion of EXO1 alone is not sufficient
for fork stabilization. Forks are unable to restart when released from HU arrest even in a rad53∆exo1∆
background similar to rad53∆ [224]. Thus, Rad53 has Exo1-independent functions at maintaining
fork integrity.
In fission yeast, Cds1 phosphorylates and activates Dna2, a helicase/nuclease, which prevents
accumulation of reversed forks [226]. In human cells, DNA2 is involved in the processing and
restart of reversed forks [227,228]. Thus, the checkpoint modulates fork reversal by activating or
inhibiting nucleases.
11.6. Restart of Stalled Forks
The ultimate question of how the checkpoint restores progression of stalled forks beyond the
lesion is just being uncovered. As mentioned above, stalled forks can undergo fork reversal even
in the presence of checkpoint. In human cells, reversed forks are restarted in a RECQ1 and DNA2
dependent manner [227,229]. Mus81-Eme1, a structure specific endonuclease, is normally active
only during mitosis due to the requirement of phosphorylation by CDK1 and Polo-like kinase 1
(Plk1) for activation [230–232]. However, several recent studies suggest that Mus81 could also play a
role in fork restart mechanisms during S phase by creating double strand breaks and promoting
recombination [233–241]. In human cells, fork cleavage and restart of stalled forks in S phase
is governed by Mus81-Eme2, while the G2/M functions of Mus81 are guided by Mus81-Eme1
complex [234,236,237]. SMARCAL1 may also be an important candidate, as it possesses both fork
reversal as well as fork restoration activities, and is regulated by ATR [190,212,213]. However, its exact
function at stalled forks in vivo is yet to be determined.
In the case of stalled forks that have not reversed, restart or restoration of fork progression occurs
mainly in three ways: by repriming (Figure 2c), by translesion-polymerase-based synthesis (TLS)
(Figure 2d), or by template switching (Figure 2e) [242–248]. Lesions on the lagging strand can be
easily bypassed due to the discontinuous nature of lagging-strand synthesis. However, lesions on
the leading strand must be actively bypassed using various mechanisms in order to continue DNA
synthesis. The first evidence that lesion bypass via repriming downstream could be employed in
the case of leading strand comes from studies done in bacteria. Bacterial replisomes are capable of
repriming and re-initiating replication in response to UV-induced lesions (Figure 2c) [249,250]. Recent
discovery of similar activity by PrimPol in human cells shows that repriming downstream may be an
evolutionarily conserved approach. PrimPol, which has primase as well as translesion polymerase
activity, allows repriming of stalled forks in response to UV as well as dNTP depletion [251–253].
Furthermore, EM studies suggest that repriming activities on leading strand in response to UV occurs
in budding yeast, too [254], although it must be via a distinct mechanism, because PrimPol is not
conserved in yeast [255].
The TLS and template switching mechanisms of fork restart are regulated by ubiquitination
of the proliferating cell nuclear antigen (PCNA) [256–258]. ssDNA generated in response to
replication stress recruits Rad18, which, along with Rad6, monoubiquitinates PCNA at K164 [256,259].
Monubiquitination of PCNA allows recruitment of translesion polymerases, which have low fidelity,
allowing the fork to replicate across damaged bases (Figure 2d) [260–262]. Although translesion
polymerases permit replication across damaged template, the bypass occurs in an error prone
manner. PCNA can also be polyubiquitinated at K164 by Rad5 along with Mms-Ubc13 [256,263,264].
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Polyubiquitination of PCNA promotes template switching (Figure 2e) [265–268]. Template switching
involves usage of the undamaged sister chromatid for bypass of lesions and usually occurs in
an error free manner. Inhibition of polyubiquitination increases TLS-based mutations suggesting
competition between TLS and template switching pathways [268]. SUMOylation at K164 of PCNA
also affects template switching [269–271]. The exact role of polyubiquitination of PCNA and
how it leads to recruitment of the recombination factors necessary for template switching are not
known [242,245,258,272]. Regulation and crosstalk across various modifications on PCNA and the role
of checkpoint in mediating lesion bypass are also poorly understood. Furthermore, PCNA functions
as a trimmer at the replication fork. Therefore, at a single stalled fork, individual copies of PCNA
may harbor different modifications and the trimmer collectively may regulate the mechanism of lesion
bypass [242,245,247,272].
12. Conclusions
The intra-S checkpoint plays a crucial role in maintaining genomic stability in response to various
kinds of DNA damage. The checkpoint maintains genomic stability primarily by regulating origin
firing, fork progression, and G1/S transcription in response to DNA damage. Of the three, regulation
of forks is perhaps the most critical function of the checkpoint but its mechanisms remain largely
unclear and controversial. Important insight into the role of fork regulation comes from EM studies,
which have helped us uncover the structural alterations observed at stalled forks, and from in vitro
biochemical studies with fork components and artificial templates, which have allowed us to decipher
their catalytic functions. However, how the fate of a stalled fork is determined by the interplay of
various factors in vivo is unclear. Recent advances using new techniques such as iPOND (isolation of
proteins on nascent DNA) have led to identification of new players at stalled forks [273–276]. Although
the list of proteins associated with the stalled fork grows, their regulation by the checkpoint is yet to be
elucidated. In the future, direct observation of the resolution of stalled forks, as well as the ability to
monitor single molecules of protein in action at the fork, will be critical to furthering our understanding
of checkpoint mediated stable progression of replication forks through damaged templates.
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